Shared mobile devices deliver significant benefits to clinical workflows and patient care, but gaps in user experience, oversight, and policy enforcement still limit their full impact Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today released new global research revealing that 92% of healthcare leaders now consider mobile devices…
As the global digitalization of healthcare accelerates, data assetization, AI-driven collaboration, and insurtech are becoming core breakthroughs in the industry. Recently, the healthcare data infrastructure platform Qyntria announced that its token, QYN, has officially launched on the internationally compliant trading platform QuotientX. This not only signifies Qyntria’s successful entry into the global digital asset circulation system…
Strengthening technology innovation and leadership of the Certara AI/ML-enabled biosimulation platform used to speed time to market in drug discovery and development Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Christopher Bouton, Ph.D., as Chief Technology Officer. In this role, Bouton will lead technology strategy and development…
HomeTown Health University (HTHU) proudly announces the launch of its new “Artificial Intelligence Practitioner in Rural Health” (AI-PRH) certification program. This pioneering initiative equips professionals in rural healthcare with expertise, skills, and confidence to harness artificial intelligence (AI) for transforming patient care, enhancing operational efficiency, and positively impacting health outcomes. “AI is rapidly transforming healthcare,…
As restrictions tighten on compounded semaglutide, FuturHealth now offers name-brand GLP-1s—like Wegovy®— through Novo’s cash-pay program FuturHealth, a leading provider of personalized weight-loss solutions, today announced it is giving its members seamless access to FDA-approved GLP-1 medications – including Wegovy® – at highly affordable, cash-pay prices, delivered directly to their doors. This service is enabled by the…
Strategic Deployment of SUPERWISE®’s Enterprise AI Platform Enhances Renova’s RCare System with Intelligent Workflows, Better Documentation, and Human-Centered Automation SUPERWISE, a trusted Enterprise AI Governance and Operations Platform, today announced the successful implementation of its cutting-edge AI solutions with Renova Health, a leader in chronic care management. This strategic deployment by SUPERWISE leverages its advanced…
Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, and illumiSonics Inc., a leader in label-free optical imaging and computational pathology, today announced successful research demonstrating compatibility between illumiSonics’ research-use only Multi-Laser Imaging (MLI) system and Modella AI’s research-use only PathChat DX platform, which has been granted a Breakthrough Device Designation by…
Aetna Care Paths, a first-to-market care option available in the Aetna Health app, makes it easier and simpler for members to get the care they need AI enabled clinical solutions enhance the human touch, giving nurses 90 more minutes a day to spend with members To make the health care system easier to navigate, Aetna,…
Findings from Western University, QIMR Berghofer, and Rotman Research Institute underscore the power of Creyos in detecting early risk, validating digital testing, and uncovering markers of cognitive resilience. Used in over 400 peer-reviewed studies, Creyos continues to power cutting-edge brain health research around the world. Creyos, the digital platform trusted by clinicians and researchers to assess brain…
Today at ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), researchers will unveil a blood test developed with the help of artificial intelligence (AI) that identifies Lyme disease sooner and more accurately than the current standard — and that could translate to vastly improved patient outcomes. A second study highlights how…